The Assessment of Metformin Treatment on Coronary Collateral Development in Patients with Type 2 Diabetes Mellitus  by Tan Kürklü, Türkan Seda et al.
O
R
A
L
SCoronary Heart Diseases
Tuesday, October 29, 2013, 08:30 AM–09:45 AM
Hall: SARAJEVO
Abstract nos: 158-163
OP-158
The Beta-Fibrinogen 455 G/A Gene Polymorphism Associated with Coronary
Artery Disease
Atilla _Içli1, Ahmet Altınbas¸2, Yasin Türker3, Recep Sütçü4, Salaheddin Akçay5,
Habil Yücel6, Özkan Görgülü7, Hasan Aydın Bas¸2, Fatih Aksoy2, Bayram Ali Uysal2
1Department of Cardiology, Ahi Evran University Education and Research Hospital,
Kırsehir, 2Department of Cardiology, Suleyman Demirel University, Isparta,
3Department of Cardiology, Duzce University, Düzce, 4Department of Biochemistry,
Katip Celebi University, _Izmir, 5Department of Cardiology, Celal Bayar University,
Manisa, 6Department of Cardiology, Isparta State Hospital, Isparta, 7Department of
Biostatistics and Medikal _Informatics, Ahi Evran University Education and Research
Hospital, Kirsehir
Background: The genetic model underlying a multifactorial disease such as coronary
artery disease (CAD) is complex as it embodies a potpourri of genes and environ-
mental factors. Accordingly, studies have averred that the polymorphisms in the
components of renin-angiotensin-aldosterone system are important in the development
and progression of CAD. We investigated relationship between b-ﬁbrinogen 455 G/A
gene polymorphism and CAD.
Methods: Sixty ﬁve patients with CAD (mean age 557years) and 65 patients with
normal coronary angiograms (mean age 517 years) were included in the study. The
types of b-ﬁbrinogen 455 G/A gene polymorphisms were analysed by polymerase
chain reaction and restriction fragment length polymorphism. For each polymorphic
position, one of three possible patterns may be obtained: Normal (GG) genotype,
heterozygous (GA), or homozygous (AA) mutant genotype. Demographic character-
istics and major risk factors for atherosclerosis were evaluated in the study groups.
Results: There was no signiﬁcant difference with respect to age and gender between
groups. The frequency of the GA heterozygous genotype was signiﬁcantly higher in
CAD group than controls (37 (%56.9) vs 25 (%38.5), p¼0.035). The frequency of the
AA homozygous mutant genotype was signiﬁcantly higher in CAD group than
controls (8 (%12.3) vs 1 (%1.5), p¼0.016). Between the two groups were compared
according to the dominant genetic model (GA+AA vs. GG), The number of patients
carrying at least one A mutant allele (GA+AA) were signiﬁcantly higher in CAD than
controls (45 (%69.2) vs 26 (%40), p¼0.001). With respect to allelic distribution (G vs
A, additive model), the frequency of the A mutant allele was signiﬁcantly higher in
CAD patients. (53 (%40.7) vs 27 (%20.7), p¼0.001).
Conclusions: In this study, we found that the frequency of b-ﬁbrinogen 455 G/A gene
polymorphism was higher in patients with CAD compared to control subject.
However, further large-sized studies are required for determining relationship between
b-ﬁbrinogen 455 G/A gene polymorphisms and CAD.General
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Association between Vitamin D Levels and Cardiac Syndrome X
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Aim: The effect of Vitamin D on cardiovascular health is controversial. Cardiac
syndrome X which is angina-like chest pain, a positive result from a stress test and
normal coronary arteries is encountered frequently in cardiology practice. Cardiac
syndrome X patients are frequently admitted to hospital. We investigated vitamin D
levels in cardiac syndrome X patients.
Methods: In all 95 patients (13 patients with cardiac syndrome X, 47 patients with
coronary artery disease and 35 control subjects) were enrolled. 25(OH) D3 levels were
measured in all participants in winter season. We compared vitamin D levels between
the groups.
Results: Vitamin D levels were different between the 3 groups (p<0.001). Vitamin D
levels were lower in patients with cardiac syndrome X than in controls (18.88.6 mg/
L vs. 30.116 mg/L; p<0.001) but vitamin D levels were similar in patients with
cardiac syndrome X and coronary artery disease (18.88.6 mg/L vs. 19.38.9 mg/L; P
NS) (Figure 1).JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORAConclusion: Vitamin D levels were reduced in cardiac syndrome X patients similarly
to with coronary artery disease. This suggests that vitamin D deﬁciency could inﬂu-
ence coronary ﬂow. Whether correction of Vitamin D deﬁciency can help to reduce
hospital admissions in patients with cardiac syndrome X and it needs to be studied
further.Coronary Heart Diseases
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Background: Metformin is a biguanid class, oral antidiabetic drug used in patients
with type 2 Diabetes Mellitus (DM). By increasing insulin sensitivity in tissues,
metformin mitigates insulin resistance which is the most important factor causing
endothelial dysfunction. It is known that metformin limits the infarct size after
myocardial infarction, reduces aneurysm development and remodeling in the ventricle
even in the prediabetic period. The current study was undertaken to assess the effects
of metformin therapy on coroner collateral development in type 2 diabetes patients.
Material-Methods: Study population consisted of 152 consecutive patients who have
undergone coronary angiography and who had at least one major coronary artery
stenosis of 95%. Coronary collateral circulations were graded from 0 to 3 according
to the Cohen-Rentrop method. And, collateral grading was classiﬁed as poor collateral
development when the collateral grade was 0 to 1, and as good collateral development
when the grade was 2 to 3. The effect of metformin therapy on the coronary collateral
growth was analyzed. Furthermore, patients taking metformin were divided into two
subgroups as high-dose (>1000 mg) and low-dose (1000 mg) patients. So, the effect
of the dosage of the drug on coronary collateral development was also assessed.
Results: The mean age of the study population was 65,249,71 years. 89 of the cases
(58,55%) were males, and 63 of them (41,45%) were females. No statistical difference
was determined between the groups’ demographic and laboratory characteristics.
Metformin therapy had no effect on coronary collateral development according to the
Rentrop classiﬁcation (p¼0,657). Correspondingly, good and poor coronary collateral
formations of the groups were similar (p¼0,837). 31 patients (63,30%) in the high-
dose metformin group were identiﬁed as having good collaterals, whereas only 7 cases
(31,80%) of the low-dose group had good collaterals. In conclusion, patients who
have used high-dose metformin had signiﬁcantly better coronary collaterals
(p¼0,014).
Conclusions: In our study, we have found that metformin therapy had no effect on the
development of coronary collaterals in the patients with type 2 DM. In contrast,
patients who were on high-dose metformin therapy had signiﬁcantly better coronary
collateral development. To the best of our knowledge, this is the ﬁrst study evaluating
the effects of metformin on coronary collateral formation. Finally, larger, prospective
studies are necessary to ﬁnd out the effects of metformin treatment on coronary
collateral development.LS C71
Good and poor collateral development according to the metformin dosage
Low-dose
metformin
(n¼ 22)
High-dose
metformin
(n¼ 49) p
Good collaterals, (%) 7 (31,8) 31 (63,3) 0,014
Poor collaterals, (%) 15 (68,2) 18 (36,7)
Table 1. Frequencies of CAC and CAD with Chi-Square and Correlation test
results
CAD positive CAD negative Total
Calciﬁcation
positive
77 (81,9%) 17 (18,1%) 94 (27,8%)
Calciﬁcation
negative
135 (55,3%) 109 (44,7%) 244 (72,2%)
Total 212 (62,7 %) 126 (37,3%) 338 (100%)
Pearson chi-Square
value: 20,515, p
<0,0001
Continuity
Correction value:
19,393, p<0,0001
Pearson
Correlation
value:0,246,
p<0,0001
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Is Calculated SCORE Risk Reliable in Asymptomatic Atherosclerosis? Sarajevo
Survey on Vascular/Heart Ageing
Mirza Dilic
Clinical Center University of Sarajevo, Bosnia and Herzegovina
Aim: Aim of this article is to present our own, Bosnia and Herzegovina survey in
patients with asymptomatic atherosclerosis and to compare European SCORE risk
estimation and 2008 Framingham Risk tables on our sample of patients. In fact, 2008
Framingham Risk table included a concept of vascular/heart ageing. On the other hand
a European SCORE system was basically aimed to quantify the absolute 10 years
(fatal) cardiovascular risk. SCORE risk estimation and vascular ageing was modify in
updated version of European guidelines but still it is insufﬁcient. Cuende et al. (2010)
suggests a new method of cardiovascular risk evaluation.
Materials-Methods: Sarajevo survey was conducted on the sample of completely
(100%) asymptomatic patients (n-358). Participants were of 40-69 yrs, average yrs.
57.19.2, 142 females and 216 males. We performed non-invasive screening of aorta,
carotid, iliac and femoral vessels and found asymptomatic atherosclerotic disease
(atheroplaques) in 43,1% individuals and signiﬁcance was of p<0,001. We found
atherosclerotic plaques of various degrees in age subgroups; 40-49 yrs (18,3%), 50-59
yrs (48,9%), 60-69 yrs (32,7%). Calculation of fatal CVD risk on the basis of SCORE
scale for high-risk European countries, due to age subgroups, was as follows; 40-49
yrs (2%), 50-59 yrs (3,45%) and 60-69 yrs (8,90%), respectively. Due to Cuende
modiﬁcation of SCORE tables their average vascular/heart age was signiﬁcantly
higher than their actual calendar age, and average vascular/heart age was higher for
14,5 yrs, p<0,001. After this results we underwent recalculating of vascular/heart age
according to 2008 Framingham Risk Tables and we found 16,8 yrs higher results i.e.
in age subgroup of 50-59 yrs, vascular/heart age was 75,9 yrs, and for age subgroup of
60-69 yrs, vascular/heart age was 85,3 yrs.
Conclusion: after these results we can conﬁrm that current SCORE system under-
estimate real risk, especially in individuals with asymptomatic atherosclerosis and do
not “recognized“ them as high risk population. On the other hand it is very clear that
ofﬁcial statistics for Bosnia and Herzegovina; morbidity of 11.800/100000 inhabi-
tants, and mortality of 578/100000, are not correct. In fact, morbidity and mortality in
our population is much more higher. On the basis of this results and other studies, as
well, we must introduced risk estimation of cardiovascular risk factors on the basis of
vascular/heart age to achieve real data and real “mirror“ of our cardiovascular situa-
tion. We want to underline that we have to focused on identiﬁcation of risk and high-
risk asymptomatic individuals and immediately act in order to decrease our rates of
morbidity and mortality.
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Aim: Angiopoietin like protein-2 (Angptl2), a proinﬂammatory protein, has been
demonstrated to accelerate atherosclerosis in animal models through enhanced adhe-
sion of leukocytes to endothelial cells. The aim of this study is to investigate theC72 JACC Vrelationship between serum Angptl2 levels and the angiographic severity and extent of
coronary artery disease.
Methods: One hundred and thirty-four individuals who underwent coronary angi-
ography due to a positive stress test were included in the study. Individuals who had at
least 50% stenosis in a major epicardial artery and a Gensini score 20 constituted the
patient group (n¼68), and those who did not have any signiﬁcant stenosis and with
a Gensini score <20 constituted the control group (n¼66). Serum Angptl2 levels were
determined using the ELISA method.
Results: Serum Angptl2 levels were signiﬁcantly higher in the patient group when
compared to the control group (49.829.0 ng/mL vs. 38.820.3 ng/mL, respectively;
p¼0.017). There was a positive and signiﬁcant correlation between serum Angptl2
levels and the Gensini score (r¼0.206, p¼0.021). In multivariate analysis, Angptl2
level was an independent predictor of signiﬁcant CAD.
Conclusion: Serum levels of Angptl2 are higher in individuals with signiﬁcant CAD
when compared to those without, and Angptl2 levels are positively correlated to the
severity and extent of CAD. The exact role of Angptl2 in CAD pathogenesis and its
potential value as a therapeutic target should be elucidated with further studies.
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The Relationship Between Fluoroscopically Detected Coronary Artery
Calciﬁcation and Coronary Artery Disease
Yalçın Boduroglu, Barbaros Dokumacı, Yusuf Erzurum
Eskisehir Private Sakarya Hospital, Eskisehir
Introduction: Fluoroscopically detected coronary artery calciﬁcation is aproven
modality for prediction of coronary artery disease (CAD) in asymptomatic patients. In
one research the predictive accuracy of CAC in asymptomatic male patients was very
high (100% for CAD and 92% for clinically signiﬁcant CAD) Fluroscopically
calciﬁcation ﬁnding conﬁrmed the presence of already existing signiﬁcant stenosis on
the coronary artery or a high risk for hemodynamic disorder in another study. The
SYNTAX score is a unique tool to score complexity of coronary artery disease. We
wanted to investigate the relationship between ﬂuoroscopically detected coronary
artery calciﬁcation (CAC) and burden of CAD in consecutive patients using syntax
score.
Methods: Fluoroscopically detected CAC was investigated in 338 patients in
outpatient clinic. All patients were underwent coronary angiography. The relationship
between ﬂuoroscopically detected calciﬁcation and burden of coronary artery disease
using syntax score and number of disease vessel were researched. Coronary calciﬁ-
cation density, lengthiness, localization and accompanied with thrombus and other
features were recorded. All statistical analysis were done by using SPSS 18.
Results: Most of the patients were asymptomatic (89%) but the others had chest pain
symptoms. (11%) There were 230 male patients (68%, mean age 622 years old), 108
female patients. (32%, mean age 653 years old) Hypertension was in 78%, type 2
diabetes mellitus in 17%, hyperlipidemia in 35% and smoking in 33%. Fluoroscop-
ically detected CAC were found in 94 patients (27,8%) and not found in 244 patients
(72,2%). 212 patients (62,7%) had CAD and 126 patients (37,3%) didn't have. 95
patients (28,1%) one vessel, 117 patients (34,6%) had two or more CAD. We can see
crosstabs table of frequency distribution of CAC & CAD in table 1. Correlation
analysis showed weak correlation between CAC & CAD but reached statistical
signiﬁcance.(Table1)
Pearson chi-Square value: 20,515, p<0,0001 and Continuity Correction value:
19,393, p<0,0001. Pearson Correlation value: 0,246, p<0,0001
The sensitivity of CAC for detection CAD was 77,3% and speciﬁty was 86,5%.
Positive predictivity was 81,9% and negative predictivity 44,6%. (Table2) Also there
was a good relationship between CAC and possibility of 2 or more vessel CAD.
(Table3) (p<0,0001) Findings of positive ﬂuoroscopically CAC meant more inter-
mediate and high Syntax score than negative CAC. (Table 4) Fluorocopically detected
CAC was found to have a correlation with many ﬁndings of CAD so maybe in the
future that will be more common in screening asymptomatic patients in outpatient
clinics.
Conclusions: Our study showed that ﬂuoroscopically detected CAC was easy and
conﬁdential method to screen many patients. The value of the method will be rised
with more trials.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
